QT Medical Closes $12 Million Series B Financing

QT Medical® has closed $12 Million Series B Financing led by CDIB Capital and Taiwania Capital, followed by Cathay Capital, BE Capital, TMU Biomed, and existing investor Quanta Computer, to accelerate its market penetration, global expansion, product pipeline development, and long-term strategic planning.

QT Medical is a medical device company that aims to make hospital-grade 12-lead electrocardiograms (ECGs) accessible to everyone. Its flagship product, the Personal Cardiac Assistant (PCA 500)™, is the only hospital-grade, resting 12-lead ECG device cleared by the FDA and CE marked for both professional and patient use. The PCA 500 is currently being used across the continuum of care, including on commercial flights for inflight medical emergencies, in schools to identify student athlete risks for sudden cardiac arrest, in clinical trials for cardiac safety testing, as well as in urgent care centers, nursing homes, hospitals, digital health clinics, and by thousands of patients at home for self-care supervised by physicians.

This financing round is crucial for QT Medical to accelerate growth and develop long-term strategies. We are changing the performance and delivery of cardiac care services by healthcare professionals and bringing this technology to millions of patients with heart disease for self-care at home,” said Ruey-Kang Chang, CEO of QT Medical.

To view the source version, please click HERE.